Potential of sarar for radiolabelling peptides and antibody fragments with CU‐64
- 1 May 2001
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 44 (S1) , S691-S693
- https://doi.org/10.1002/jlcr.25804401244
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Copper radionuclides and radiopharmaceuticals in nuclear medicineNuclear Medicine and Biology, 1996
- Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.Proceedings of the National Academy of Sciences, 1996